These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 20358644)
1. The RON tyrosine kinase receptor regulates vascular endothelial growth factor production in pancreatic cancer cells. Thomas RM; Jaquish DV; French RP; Lowy AM Pancreas; 2010 Apr; 39(3):301-7. PubMed ID: 20358644 [TBL] [Abstract][Full Text] [Related]
2. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Summy JM; Trevino JG; Baker CH; Gallick GE Pancreas; 2005 Oct; 31(3):263-74. PubMed ID: 16163059 [TBL] [Abstract][Full Text] [Related]
3. VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells. Doi Y; Yashiro M; Yamada N; Amano R; Noda S; Hirakawa K Ann Surg Oncol; 2012 Aug; 19(8):2733-43. PubMed ID: 22207048 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling. Anandanadesan R; Gong Q; Chipitsyna G; Witkiewicz A; Yeo CJ; Arafat HA J Gastrointest Surg; 2008 Jan; 12(1):57-66. PubMed ID: 18026817 [TBL] [Abstract][Full Text] [Related]
5. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells. Mabjeesh NJ; Willard MT; Frederickson CE; Zhong H; Simons JW Clin Cancer Res; 2003 Jul; 9(7):2416-25. PubMed ID: 12855613 [TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. Sun Y; Wu C; Ma J; Yang Y; Man X; Wu H; Li S Exp Cell Res; 2016 Oct; 347(2):274-82. PubMed ID: 27426724 [TBL] [Abstract][Full Text] [Related]
7. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells. Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103 [TBL] [Abstract][Full Text] [Related]
8. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Adya R; Tan BK; Punn A; Chen J; Randeva HS Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor over-expressed mesenchymal stem cells-conditioned media ameliorate palmitate-induced diabetic endothelial dysfunction through PI-3K/AKT/m-TOR/eNOS and p38/MAPK signaling pathway. Xu T; Lv Z; Chen Q; Guo M; Wang X; Huang F Biomed Pharmacother; 2018 Oct; 106():491-498. PubMed ID: 29990837 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. O'Toole JM; Rabenau KE; Burns K; Lu D; Mangalampalli V; Balderes P; Covino N; Bassi R; Prewett M; Gottfredsen KJ; Thobe MN; Cheng Y; Li Y; Hicklin DJ; Zhu Z; Waltz SE; Hayman MJ; Ludwig DL; Pereira DS Cancer Res; 2006 Sep; 66(18):9162-70. PubMed ID: 16982759 [TBL] [Abstract][Full Text] [Related]
11. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model. Kowshik J; Giri H; Kishore TK; Kesavan R; Vankudavath RN; Reddy GB; Dixit M; Nagini S Anticancer Agents Med Chem; 2014; 14(9):1249-60. PubMed ID: 25060902 [TBL] [Abstract][Full Text] [Related]
13. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. Wang D; Donner DB; Warren RS J Biol Chem; 2000 May; 275(21):15905-11. PubMed ID: 10748050 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. Yao HP; Feng L; Suthe SR; Chen LH; Weng TH; Hu CY; Jun ES; Wu ZG; Wang WL; Kim SC; Tong XM; Wang MH J Immunother Cancer; 2019 Mar; 7(1):75. PubMed ID: 30871619 [TBL] [Abstract][Full Text] [Related]
15. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Findley CM; Cudmore MJ; Ahmed A; Kontos CD Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2619-26. PubMed ID: 17901375 [TBL] [Abstract][Full Text] [Related]
16. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
17. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Tang Y; Nakada MT; Rafferty P; Laraio J; McCabe FL; Millar H; Cunningham M; Snyder LA; Bugelski P; Yan L Mol Cancer Res; 2006 Jun; 4(6):371-7. PubMed ID: 16778084 [TBL] [Abstract][Full Text] [Related]
18. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells. Wang J; Yang L; Liang F; Chen Y; Yang G J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824 [TBL] [Abstract][Full Text] [Related]
19. p38 MAPK mediates gamma-irradiation-induced endothelial cell apoptosis, and vascular endothelial growth factor protects endothelial cells through the phosphoinositide 3-kinase-Akt-Bcl-2 pathway. Kumar P; Miller AI; Polverini PJ J Biol Chem; 2004 Oct; 279(41):43352-60. PubMed ID: 15292252 [TBL] [Abstract][Full Text] [Related]
20. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling. Chen HM; Tsai CH; Hung WC Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]